Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 randomized double-blind SAD/MAD study of topical M132101 in healthy males
jRCT2071230113Phase 1Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of M132101 in Capillary Haemangioma (4 arms), sponsored by Maruho Co., Ltd. Primary endpoints: Tolerability, Safety and 1 more. Started Mar 2024; status: completed.
02
Drugs
M132101
03
Conditions
Capillary Haemangioma
Beyond the preview
Go deeper on jRCT2071230113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071230113.